Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review.

Anaesthesia

Department of Anaesthesia, Critical Care and Pain Medicine, Tallaght University Hospital, Dublin, Ireland.

Published: May 2023

Propfol-remifentanil-based total intravenous anaesthesia has dominated recent clinical practice due to its favourable pharmacokinetic profile. Interruption in remifentanil supply has presented an opportunity to diversify or even avoid the use of opioids and consider adjuncts to propofol-based total intravenous anaesthesia. Propofol, while a potent hypnotic, is not an effective analgesic. The administration of opioids, along with other adjuncts such as α-2 adrenoceptor agonists, magnesium, lidocaine, ketamine and nitrous oxide provide surgical anaesthesia and avoids large doses of propofol being required. We provide an overview of both target-control and manual infusion regimes for the alternative opioids: alfentanil, sufentanil and fentanyl. The optimal combination of hypnotic-opioid dose, titration sequence and anticipated additional postoperative analgesia required depend on the chosen combination. In addition, we include a brief discussion on the role of non-opioid adjuncts in total intravenous anaesthesia, suggested doses and expected reduction in propofol dose.

Download full-text PDF

Source
http://dx.doi.org/10.1111/anae.15952DOI Listing

Publication Analysis

Top Keywords

total intravenous
16
intravenous anaesthesia
16
anaesthesia
5
alternatives remifentanil
4
remifentanil analgesic
4
analgesic component
4
total
4
component total
4
intravenous
4
anaesthesia narrative
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!